✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Lercanidipine is a 1,4-dihydropyridine calcium channel blocker.
📊
Key Findings & Data:This case report describes our clinical experience regarding the treatment of Lercanidipine overdose in a 16-year-old girl.
💡
Conclusion & Impact:To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Lercanidipine is a 1,4-dihydropyridine calcium channel blocker. For severe toxicity, treatment modalities are based on a restricted range of evidence and clinical experience. This case report describes our clinical experience regarding the treatment of Lercanidipine overdose in a 16-year-old girl. To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine
🔖
Cite This Article
Bayar, V. (2022). Lercanidipine Intoxication in A 16-Year-Old Adolescent. Trends in pediatrics, Cilt: 3 - Sayı: 2, 54–57. https://ajindex.com/articles/598877